Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-02-22 @ 9:55 AM
Study NCT ID:
NCT00849550
Status:
COMPLETED
Last Update Posted:
2012-12-24
First Post:
2009-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.
Sponsor:
Herbert Hurwitz
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00015605
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None